论文部分内容阅读
由于各种休克的病因学和病理生理学各不相同,因而治疗效果较难判断。对于心源性、败血性和手术后休克,多巴胺在综合治疗中的作用可能比去甲肾上腺素和异丙基肾上腺素优越,特别是可改善左心室功能和肾血流量。但是,至今大多数研究未能证实有明确的死亡率降低;急性心肌梗塞后的心源性休克用多巴胺亦未能获得持久
Because of the various etiologies and pathophysiology of shock vary, so the treatment is difficult to judge. For cardiogenic, septic and postoperative shock, the effects of dopamine in combination therapy may be superior to norepinephrine and isoproterenol, in particular to improve left ventricular function and renal blood flow. However, to date, most studies have failed to confirm a definitive reduction in mortality; cardiogenic shock following acute myocardial infarction has also failed to achieve sustained survival with dopamine